Summary
The Netherlands Cancer Institute is offering a PhD position focused on early response prediction and recurrence detection in patients with resectable melanoma using liquid biopsies. This project aims to enhance personalized surveillance methods through the analysis of circulating tumor DNA (ctDNA).
Designation
PhD Candidate in Molecular Oncology
Table
| Category | Details |
|---|---|
| Research Area | Molecular Oncology, Liquid Biomarkers, Cancer Surveillance |
| Location | Netherlands Cancer Institute, Amsterdam |
| Eligibility/Qualification | Master’s degree in Biomedical Sciences, Oncology, Biology, or a related field; Experience in laboratory research; Strong understanding of molecular biology and oncology. |
| Salary | € 3.738 – € 4.539 per month |
| Contract Duration | 4 years |
Description
The PhD position is situated within the research group led by Daan van den Broek. The project seeks to validate a ctDNA-based surveillance strategy for stage III melanoma patients post-surgery, moving beyond traditional methods that primarily depend on clinical assessments and imaging.
Key Responsibilities:
- Optimize and validate a melanoma surveillance assay for clinical applications.
- Conduct molecular analyses of ctDNA data from a large cohort of patients.
- Develop multimodal classifiers integrating various data sources.
- Design research studies and prepare manuscripts.
- Manage the project and supervise students.
How to Apply
Interested candidates should apply through the official application button on the webpage. Applicants need to submit:
- A motivation letter
- A CV
- Contact details of two references
Please ensure that reference information is included with your application documents, as there is no option for separate submission.
Last Date to Apply
Applications will be accepted until Sunday, March 22, 2026.
For further inquiries, you can contact:
- Paul van der Leest (Postdoctoral Fellow) at p.vd.leest@nki.nl
- Daphne Heemskerk (Recruitment) at d.heemskerk@nki.nl
